Destination

2025-01-13

The King of Ozempic Is Scared as Hell

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics? [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination

2025-03-07

Apple Music gives Britain's monarch the aux

It turns out everyone likes to share their music suggestions, even monarchs. Apple Music has announced a new show called The King's Music Room, hosted by King Charles III at Buckingham Palace. Ye [...]

Match Score: 52.18

Destination

2025-03-21

The Morning After: A closer look at Facebook’s leadership

For all of the money and clout Meta has, it can’t stop the triennial emergence of a whistleblower revealing how awful its leadership is. Careless People, the tell-all memoir from former staffer Sara [...]

Match Score: 52.18

Destination

2025-02-24

Xbox showcase gave release dates for three indie games we're looking forward to

Monday's ID@Xbox indie showcase included release dates for a few upcoming games we've been tracking. 33 Immortals, which lets you round up 32 pals to try to escape hell with, arrives next mo [...]

Match Score: 47.40

Destination

2025-04-13

Meta Neuroscientist King: "Some of the concepts like reasoning may need to be re-evaluated"

The neuroscientist Jean-Rémi King leads the Brain & AI team in Meta’s AI division. In an interview with The Decoder, he discusses the connection between AI and neuroscience, the challenges of l [...]

Match Score: 44.73

thenextweb

2025-01-10

Verdiva launches with $410M for weight loss drugs to challenge Ozempic, Wegovy

London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]

Match Score: 42.05

Destination

2025-03-07

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]

Match Score: 42.05

Destination

2025-03-10

Novo Nordisk's Ozempic successor disappointed Wall Street again

Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more... [...]

Match Score: 42.05

Destination

2025-04-01

Here's how much Ozempic and similar drugs have soared in popularity since 2018

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.R [...]

Match Score: 42.05

Destination

2025-01-06

The Morning After: This robot vacuum has a robot arm

At CES 2025 in Las Vegas, which kicks off this week, Roborock, a Chinese manufacturer of robot vacuums and other household cleaning appliances, has unveiled a new robotic vacuum model with a foldable [...]

Match Score: 39.50